דינמיקת הכנסות משנה לשנה ב-12 החודשים האחרונים: Scienture Corp (SCNX)

Scienture Holdings Inc (SCNX) combines the TRxADE B2B platform for the pharmacy sector with the development of CNS drugs, mitigating niche risks through SaaS subscriptions for pharma clients. The trailing four-quarter annual revenue growth rate confirms expansion, where the value of -73.20 expresses the metric level. Cash flow stability is based on recurring payments for clinic automation and medical digitalization.
פילוחי נתונים אנליטיים מרוכזים עבור Scienture Corp (SCNX)

For Scienture Holdings Inc (SCNX), this indicator serves as a tool for real-time monitoring of revenue dynamics. The metric calculates the daily change in sales volume over a rolling year, eliminating quarterly gaps. By analyzing comparable year-over-year sales growth over 12 months, an investor can identify the current business scaling trend. This allows for tracking the impact of server equipment costs on the margins of IT solutions. Peak values on the chart signal a risk of overpaying for the asset.